Advanced Mycology — Research Brief

The Science

Technical profiles, comparison data, safety parameters, and purity methodology for XÜM (4-HO-MET) and PLÜR (5-MAPB). Clinical design. No marketing language.

Compound Profiles

XÜM

4-HO-MET

Metocin · Substituted Tryptamine

A synthetic 5-HT2A agonist. Already in its active form — no hepatic conversion required. Produces visually vivid, emotionally warm, and cognitively clarifying effects with a shorter duration and lower nausea profile.

  • CAS Number77872-41-4
  • FormulaC₁₃H₁₈N₂O
  • Mol. Weight218.30 g/mol
  • SolubilityWater, ethanol

PLÜR

5-MAPB

5-(2-Methylaminopropyl)benzofuran · Entactogen

A synthetic benzofuran entactogen with serotonin, dopamine, and norepinephrine releasing activity. Produces empathic, prosocial, and sensory-enhancing effects comparable to MDMA with a longer plateau, a smoother trajectory, and a lower neurotoxicity burden at equivalent empathic doses.

  • CAS Number1350537-69-7
  • FormulaC₁₁H₁₃NO
  • Mol. Weight175.23 g/mol
  • SolubilityWater (HCl salt)

Comparison Data

4-HO-MET vs Traditional Alternatives

PropertyTraditional AlternativesXÜM (4-HO-MET)
Active FormRequires conversion in body4-HO-MET (direct)
Onset30–90 min (variable)30–60 min (consistent)
Duration4–8 hours3–5 hours
Nausea / Body LoadCommonMinimal to none
Batch PurityVaries (unverified)≥ 99.2% (synthetic)
Dose PrecisionVariable potencyPer-tab mg accuracy
COA AvailableNoYes — every batch
US Federal ScheduleControlled in many statesNot scheduled

5-MAPB vs MDMA

PropertyMDMAPLÜR (5-MAPB)
Compound ClassPhenethylamineBenzofuran
Primary MechanismSERT/DAT/NET releaserSERT/DAT/NET releaser
Onset30–60 min45–90 min
Duration3–5 hours5–7 hours
Neurotoxicity RiskEstablished at high dosesLower at equivalent doses
Come-down QualityOften harshGenerally cleaner
Supply Chain PurityUnknown (street)≥ 99.2% verified
Adulterant RiskHigh (fentanyl, cathinones)None (COA verified)

Harm Reduction

Safety Profile

Both compounds are for healthy adults who have researched their use. The following parameters apply to all Advanced Mycology products.

  • ContraindicationsHeart conditions, uncontrolled hypertension, personal/family history of psychosis or schizophrenia, pregnancy, nursing
  • Drug InteractionsSSRIs, MAOIs, lithium, tramadol, antipsychotics — all contraindicated. See a pharmacist or prescriber before use.
  • Age Requirement18 years of age or older. No exceptions.
  • Set & SettingAlways use in a safe environment with trusted company or a sober guide. Do not operate machinery.
  • Start LowFirst-time users should begin at the lowest recommended dose. Effects vary by individual body chemistry.
  • FrequencyXÜM: 2–4 week minimum between sessions. PLÜR: 4–6 week minimum. Respect serotonin recovery time.

Regulatory

Legal Status

Legal status is dynamic and varies by jurisdiction. The table below reflects our best understanding at time of writing. It is not legal advice. Verify your local laws before ordering.

JurisdictionXÜM (4-HO-MET)PLÜR (5-MAPB)
United States (Federal)Not scheduledNot scheduled
United KingdomPsychoactive Substances ActPsychoactive Substances Act
GermanyNpSG (blanket ban)NpSG (blanket ban)
AustraliaControlled (varies by state)Controlled (varies by state)
CanadaControlled Drugs Act (verify)Controlled Drugs Act (verify)

Purity Methodology

COA & Testing

Every production batch of XÜM and PLÜR is tested by an independent third-party analytical laboratory before any product ships. Testing is not optional and is not performed in-house.

Method

HPLC-UV

High-performance liquid chromatography

Threshold

≥ 99.2%

Minimum acceptable purity per batch

Frequency

Every batch

No batch ships without a passing COA

Lab

Independent

Third-party — not performed in-house

Reporting

Full quantitative

Not just pass/fail — exact percentage

Access

On request

Email us with your order number

Shop XÜMShop PLÜR